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Recent findings show that human fibroblasts can be
directly programmed into functional neurons without
passing via a proliferative stem cell intermediate.
These findings open up the possibility of generating
subtype-specific neurons of human origin for thera-
peutic use from fetal cell, from patients themselves,
or from matched donors. In this study, we present
an improved system for direct neural conversion of
human fibroblasts. The neural reprogramming genes
are regulated by the neuron-specific microRNA,
miR-124, such that each cell turns off expression of
the reprogramming genes once the cell has reached
a stable neuronal fate. The regulated system can be
combinedwith integrase-deficient vectors, providing
a nonintegrative and self-regulated conversion sys-
tem that rids problems associated with the integra-
tion of viral transgenes into the host genome. These
modifications make the system suitable for clinical
use and therefore represent a major step forward in
the development of induced neurons for cell therapy.INTRODUCTION
Functional, subtype-specific neurons can be obtained by direct
conversion of human fibroblasts (Caiazzo et al., 2011; Liu et al.,
2013; Pfisterer et al., 2011a; Son et al., 2011). The resulting cells
are termed human induced neurons (hiNs). With only few excep-
tions, the growing number of studies reporting direct conversion
of fibroblasts to neurons use doxycycline-regulated lentiviral
vectors (Pfisterer et al., 2011a; Caiazzo et al., 2011; Liu et al.,
2013; Vierbuchen et al., 2010; Dell’Anno et al., 2014; Wapinski
et al., 2013). Although this technology is efficient for experi-
mental studies, it is problematic from a clinical perspective. First,
lentiviral vectors are integrating retroelements that have the ca-
pacity to affect gene expression levels of endogenous genes
that can lead to transformation events (Nienhuis et al., 2006;
Okita et al., 2008). Second, the doxycycline-regulated systems
that have been used to ‘‘shut off’’ transgene gene expressionCell Reafter conversion are not optimal for clinical use because they
contain elements of bacterial origin and require a continuous de-
livery of doxycycline to keep genes active (Gossen and Bujard,
1992). In this study, we describe an approach that circumvents
these issues and allows for generation of functional iN cells using
nonintegrating, self-regulating lentiviral vectors.RESULTS
We, and others, have previously used miRNA-regulated vec-
tors to control expression and efficiently visualize and isolate
different cell populations (A˚kerblom et al., 2013; Brown et al.,
2007; Gentner and Naldini, 2012; Sachdeva et al., 2010). In
this study, we used miR-124 to regulate neural conversion
genes. MiR-124 is expressed exclusively in neurons, is known
to promote neurogenesis in vitro and in vivo, and also has a
potential role in regulating activities of postmitotic neurons
(A˚kerblom et al., 2012; Cheng et al., 2009; Krichevsky et al.,
2006). To achieve self-regulation of our conversion vectors,
we inserted four complementary binding sites of miR-124 (Fig-
ure 1A). Thus, in cells where miR-124 is not expressed (like
the fibroblasts) the mRNA is not inhibited or degraded resulting
in high-level expression of conversion factors. When a stable
neuronal fate is reached during the conversion process, the
hiN will turn on endogenous miR-124, which will then bind
to the miR-target sequence in the vector-derived mRNA and
efficiently inhibit the expression of the conversion factors.
Thus, the system is self-regulating, alleviating the need for sup-
ply of drugs or chemicals for gene regulation. Additionally, the
regulation is achieved on a cell-by-cell basis rather than on a
population basis.
A prerequisite for the technique to work is that MiR-124 is
expressed at high enough levels in the converted neurons. To
establish this, we converted human fibroblast into hiNs by deliv-
ering lentiviral vectors coding for Ascl1, Brn2, andMyt1L (ABM).
The resulting hiNs were sorted using a human specific neural
cell adhesion molecule (hNCAM) at different time points, and
miR-124 level was monitored using locked nucleic acid (LNA)
quantitative RT-PCR (qPCR). For all time points analyzed,
the hNCAM-positive population expressed miR-124, and the
expression level increased upon maturation and then stabilized
(Figure 1B).ports 9, 1673–1680, December 11, 2014 ª2014 The Authors 1673
Figure 1. miR-124 Is a Neuron-Specific miRNA
(A) Vector maps of regulated and unregulated construct. In neurons that express miR-124, the target site (miRT) in the transcript is suppressed, resulting in no
protein translation.
(B) LNA-qRT-PCR for sorted hNCAM-positive and hNCAM-negative hiN at various maturation stage (n = 3).
(C) Schematic representation of the vectors and experimental approach to generate miR-124.T reporter fibroblast cell line and subsequent conversion to
GFP-positive and GFP-negative hiN.
(legend continued on next page)
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We next investigated the potential of miR-124-regulated vec-
tors to segregate transgene expression between human fibro-
blast and converted hiNs. We established stable GFP-express-
ing HFL1 cells with a lentiviral vector containing a GFP reporter
gene followed by four copies of perfect matching miR-124-
target sequences (HFL1-GFP-miR-124.T). Thus, GFP from this
construct is regulated by miR-124, and consequently GFP can
be used to monitor the activation of functional miR-124 during
iN conversion. We also established a nonregulated GFP-only
control cell line (HFL1-GFP). Upon conversion using ABM, the
miR-124.T-regulated GFP is expected to be downregulated
when the cells have reached a stable neuronal fate and start to
express miR-124, whereas the iNs from control cells should
remain GFP expressing (Figure 1C). In line with this, we found
that GFP levels were downregulated in hiNs obtained from
HFL1-GFP-miR-124.T upon neural conversion, whereas GFP-
levels remained high throughout the conversion period in unreg-
ulated control HFL1-GFP cells (Figures 1D and 1E). Immunoflu-
orescence staining confirmed that the hiN cells, detected
using hNCAM and MAP2, were GFP negative in HFL1-GFP-
miR124.T cells and GFP positive in HFL1-GFP control cells (Fig-
ures 1F and 1G). We observed no downregulation of GFP in the
hNCAM-negative fraction of HFL1-GFP-miR-124.T or in HFL1-
GFP control cells, confirming that downregulation of GFP only
occurs in the converted hiNs (Figures S1A and S1B). Uncon-
verted HFL1-GFP-miR-124.T and HFL1-GFP fibroblasts also ex-
pressed high-level GFP (Figures S1A and S1B). When fibroblasts
were converted with Ascl1 alone (A), or in combination with Brn2
(AB) or Myt1L (AM), no substantial downregulation of GFP were
detected (Figure S1C). These data establish that hiNs converted
using ABM start to express endogenous miR-124 that efficiently
downregulate transgene expression upon conversion using
miR-124.T-regulated vectors, validating the approach of using
this vector system for self-regulating neural conversion.
Next, we assessed whether conversion factors placed
under miR-124.T regulation could drive conversion of human
fibroblasts to neurons. We transduced HFL1 cells with the
miR-124.T-regulated conversion vectors (ABM-miR-124.T),
nonregulated ABM vectors, and also cultured untransduced
control cells in parallel (Figure S2A). Twelve days after initiation
of conversion, we found an obvious morphology change in cells
from both conversion groups (Figure S2B), and at day 24 we
found similar numbers of hiN cells expressing the neuronal
marker MAP2 (Figure S2C). No converted hiNs were detected
in the control cells grown in parallel. Quantifications performed
on days 12 and 24 posttransduction demonstrated comparable
efficiency and purity when using ABM-miR-124.T compared
to nonregulated vectors (Figures 2A, 2B, and S2D). Both the
ABM-miR-124.T- and ABM-converted hiN cells expressed the
neuronal markers NeuN (Figures 2C and 2D) and synaptophysin
(SYP, Figures 2E and 2F) when analyzed 50 days posttransduc-
tion. qPCR analysis of the resulting hiN cells showed expression
ofMAP2, Synapsin (SYN1), and SYP (Figure 2G), confirming their(D) Flow cytometry analysis of GFP positivity in hNCAM-positive cells of day 36
(E) Quantification of GFP-positive cell in hNCAM-positive cells of hiN culture at v
(F and G) hNCAM- and MAP2-positive cells derived from GFP labeled HFL1 on d
Scale bar, 100 mm. See also Figure S1.
Cell Reneuronal identity, as well as expression of genes typically ex-
pressed by GABAergic (GAD67, ISL1, and DARPP-32) and glu-
tamatergic (VGLUT, TBR1, and TBR2) neurons (Figure 2G), in a
pattern that is similar to what we have previously observed for
iN cells converted using standard vectors (Pereira et al., 2014).
These data demonstrate that miR-124.T-regulated vectors
stably convert human fibroblasts to induced neurons at the
same efficiency and purity as nonregulated vectors, without sig-
nificant effects on subtype specificity. It is worth noting that the
conversion efficiency is remarkably high in these experiments
compared to most other published studies (Ambasudhan et al.,
2011; Caiazzo et al., 2011; Davila et al., 2013; Pang
et al., 2011; Pfisterer et al., 2011a; Wang et al., 2014; Yoo
et al., 2011), and on par with the highest conversion efficiencies
that have been reported using doxycycline-regulated vectors
(Ladewig et al., 2012; Liu et al., 2013; Pereira et al., 2014). One
likely explanation for this is the use of phosphoglycerate kinase
(PGK) promoter in these studies. The PGK promoter results
in robust, ubiquitous, moderate level transgene expression,
with very little tendency to transgene silencing/variation, which
may be optimal for iN conversion.
An additional advantage of using microRNA regulation is that
the regulation is achieved in a cell-autonomous manner. Thus,
the reprogramming genes are turned off only in cells that have
reached a stable neuronal fate and not on a population basis
by withdrawal of doxycycline. This could minimize the presence
of partially reprogrammed hybrid cells that can occur if reprog-
ramming is incomplete in the cells (Okita et al., 2007; Polo
et al., 2012; Takahashi and Yamanaka, 2006).
We next used patch-clamp electrophysiology to investigate
the functional properties of the neurons obtained using the regu-
lated and nonregulated conversion system. First, we confirmed
that there were no obvious differences in the electrophysiolog-
ical properties of hiN cells generated with the standard doxycy-
cline-regulated vectors and hiNs obtained using the PGK
promoter to drive transgene expression. (Figure S2E). We then
investigated and compared the functional properties of ABM-
miR-124.T and ABM-converted hiN cells in more detail. Cells in
both groups showed functional electrophysiological properties
with evoked repetitive or single action potentials after current
injections (Figures 2H–2J, n = 20 for ABM and 11 for ABM-
miR124.T). At 60 days postconversion, a higher proportion of
ABM-mi-124.T-converted cells were able to evoke more action
potentials (Figure 2K). Both cell types exhibited fast inactivated
inward and outward current characteristic of sodium and
delayed-rectifier potassium currents (Figures 2L and 2M). How-
ever, the regulated group showed greater inward sodium cur-
rents (Figure 2N) compared to ABM nonregulated cells. Occa-
sional postsynaptic events, indicating formation of synaptic
networks, could be seen in both groups: four of 17 for ABM
and four of 19 for ABM-miR-124.T (Figure 2O). Both action po-
tentials and inward currents could be blocked with TTX (Figures
S2F–S2I). Long-term measurement at 90 days postconversionhiN culture.
arious maturation stage (n = 3).
ay 36 of hiN conversion.
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(legend on next page)
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still revealed healthy and morphologically mature neurons in
both groups, and, interestingly, at this time, regulated iNs had
started to show spontaneous firing (n = 5/11 for ABM-miR-
124.T, Figure 2P), whereas the nonregulated hiN cells did not
(n = 0/6). Taken together, these data suggest that hiN cells where
the neural conversion genes are downregulated after stable con-
version achieved more complete functional maturation than the
hiN cells where the reprogramming genes are constitutively
active also in mature neurons.
To circumvent potential positional mutagenesis caused
by integrating vectors, we next explored the possibility of con-
verting fibroblast to neurons with nonintegrative vectors. We
employed an integration deficient lentiviral vector system that
contains a point mutation D64V in the catalytic domain of HIV-
1 integrase (Lombardo et al., 2011). When we investigated the
expression from our integrative and nonintegrative vectors in
HEK293T cells, we could confirm that the nonintegrating vectors
were rapidly diluted upon cell proliferation (Figure S3A), which is
in line with the nonintegrative nature of the vector. When using
these vectors with the same conversion protocol as the inte-
grating vectors, we did observe hiN cell conversion but at a
low efficiency (Figures S3B and S3C). However, this could be
overcome by minimizing proliferation after transduction by
altering the culture conditions so that cells were switched to
neuronal medium before transduction (Figure 3A) and either
increasing the vector load or the number of vector transductions.
In this way, we reached conversion efficiencies of close to 15%
(Figure 3B). In the final step, we made nonintegrating vectors
with the miR-regulated conversion factors (ABM-miR-124.T-NI
versus ABM-miR-124.T). By using a protocol with minimized
proliferation after transduction, two transduction events, and
high vector concentration, we found that the regulated, noninte-
grative vectors converted the fibroblasts at similar efficiency, pu-
rity, andmorphology as their nonregulated counterparts (Figures
3C–3F). No iN cells were detected in untransduced control cells
cultured and analyzed in parallel. When comparing the noninte-
grative (NI) vector-based conversions, the ABM-miR-124.T was
superior to the nonregulated ABM group in the ability to evoke
action potentials (Figures 3G–3I) as well as inward sodium cur-
rent (Figures 3J and 3K). All of the recorded ABM-miR-124.T-
NI-regulated hiN (n = 7) showed single action potential (AP) after
current injections as well as inward sodium current (Figures 3G,
3I, and 3K), and one cell showed postsynaptic currents (Fig-
ure 3L). For the NI ABM nonregulated group, only one neuron
fired action potentials at current injection, whereas all the othersFigure 2. miR-124.T-Regulated Factors Generate hiN at Similar Efficie
(A and B) Quantification of conversion efficiency (A) and purity (B) of conversion
(C) qPCR analysis of resulting iN cells.
(D–G) Neuronal marker MAP2 and NeuN (D and E) and MAP2 and synaptophysin (
F) and miR-124.T-regulated conversion factors (E and G).
(H–P) Whole-cell patch-clamp measurement of miR-124.T-regulated hiN compa
induction to evoke action potential (AP). (I and J) Representative IV diagrams of di
number of APs after current injections of 30 and 40 pA compared to nonregulated
outward potassium-rectifying currents evoked by depolarizing steps to the cell. (N
to nonregulated group but similar potassium-outward currents.
(O) Both groups showed spontaneous postsynaptic currents. (P) At 90 days po
membrane potential, suggesting an integration of the hiN to the surrounding syn
Scale bar, 100 mm. See also Figure S2.
Cell Reshowed no AP and no inward sodium current (Figures 3G, 3H,
and 3J, n = 5).
DISCUSSION
A growing number of studies report successful direct neural con-
version from various somatic cells and from stem cells to func-
tional neurons (Caiazzo et al., 2011; Karow et al., 2012; Pang
et al., 2011; Pfisterer et al., 2011a; Son et al., 2011; Vierbuchen
et al., 2010; Zhang et al., 2013) and also direct conversion of so-
matic cells into a variety of mature, clinically relevant cell types
such as oligodendrocytes, cardiomyocytes, and hepatocytes
(Ieda et al., 2010; Sekiya and Suzuki, 2011; Yang et al., 2013).
Because direct conversion does not involve a stem cell interme-
diate, it has some clear benefits when it comes to developing
the cells for clinical use. However, today’s techniques for direct
conversion typically use integrating vectors that carry a risk of
genomic modifications and positional mutagenesis with the
insertion of transgenes (Lombardo et al., 2011; Nienhuis et al.,
2006; Okita et al., 2008). An added complication during direct
conversion is that the copy number of the integrated provirus
and the random genomic integration invariably will result in cell
populations that are highly heterogeneous from a genomic
standpoint.
In this study, we demonstrate that hiN cells can be obtained
using self-regulating and nonintegrating vectors that are suitable
for use in patients. Using this system, we demonstrate highly effi-
cient conversion of human fibroblast into functional neurons. We
show that the neurons survive and mature for up to 90 days in
culture, and that microRNA-mediated downregulation of the
neural conversion genes allows for a more complete functional
maturation of the cells in culture. The high efficiency, combined
with the self-regulated and nonintegrative features of this sys-
tem, represents an important step toward clinical translation of
human induced neurons (hiNs).
EXPERIMENTAL PROCEDURES
Cell-Culture Procedures
HFL1 (ATCC-CCL-153) cells were obtained from the American Type Culture
Collection (www.lgcstandards-atcc.org/products/all/CCL-153). For neuronal
conversion, fibroblasts were plated in mouse embryonic fibroblast (MEF)
medium at a density of 26,000 cells per cm2 in tissue culture plates (Nunc)
for conversion with integrative or nonintegrative viral vectors and 130,000 cells
per cm2 for nonintegrative viral vectors. To generate induced neurons from
integrative vectors, cells were grown for 3 days posttransduction in MEFncy as Unregulated Factors
factors with or without miR-124.T regulation (n = 3).
F and G) are expressed in hiN converted with regular conversion factors (D and
red to nonregulated hiN. (H) Pie chart of the different responses after current
fferent responses recorded. (K) ABM-miR124.T-regulated hiN showed a higher
ABM group suggesting a more mature phenotype. (L–M) Inward sodium- and
) Regulated ABM-miR-124.T showed greater inward sodium current compared
stconversion, the regulated group showed spontaneous firing at their resting
aptic network.
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Figure 3. Nonintegrative miR-124.T-Regulated Factors Generate hiN
(A) Proportion of hNCAM-positive cells in ABM nonintegrative (NI) hiN culture increases upon reduction of fibroblast proliferation.
(B) Conversion efficiency of various number of transduction and moi of nonintegrative conversion factors (n = 1).
(C) Flow cytometry analysis of hNCAM-positive cells of day 24 hiN culture.
(D) Quantification of conversion efficiency and purity of nonintegrative conversion factors with or without miR-124.T regulation (n = 3).
(legend continued on next page)
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medium before changing to neuronal medium containing Ndiff 227 medium
(STEMCELL Technologies), supplemented with neural trophic factors
10 ng ml1 BDNF (R&D Systems) or 2 ng ml1 LM-22A4 (R&D Systems),
2 ng ml1 GDNF, 10 ng ml1 NT3 (R&D Systems), and 0.5 mM db-cAMP
(Sigma-Aldrich). Small molecules at the following final concentrations
were supplemented on the first 14 days of neuronal medium application:
CHIR99021 (2 mM, Axon), SB-431542 (10 mM, R&D Systems), noggin
(100 ng ml1, R&D Systems), and LDN-193189 (0.5 mM, Axon). For neuronal
conversion with nonintegrative vectors, fibroblasts were either grown in MEF
medium either overnight or for 3 days posttransduction in MEFmedium before
changing to neuronal medium, or changed to neuronal medium the day after
plating, and then the cells were transduced 3 days afterward.
Generation of EGFP-Expressing Cell Line
Lentiviral constructs with PGK-GFP and PGK-GFP-miR-124.T was used to
transduce HFL1. See Supplemental Experimental Procedures for details.
Flow Cytometry Analysis and Cell Sorting
For flow cytometry analysis and cell sorting information, see Supplemental
Experimental Procedures.
Viral Vectors and Virus Transduction
Six lentiviral vectors expressing mouse open reading frames (ORFs) for Ascl1,
Brn2, and Myt1l, with or without miR-124.T regulatory unit sequence, were
generated by replacing GFP in a third-generation lentiviral vector containing
a nonregulated, ubiquitous phosphorglycerate kinase promoter with the
various ORFs (Figure S2A). Third-generation lentiviral vectors were produced
as previously described (Zufferey et al., 1997) and titrated by quantitative PCR
analysis (Georgievska et al., 2004). Transduction was always performed at
moi 5 for integrative vectors and moi 5, 10, 15 as stated for nonintegrative fac-
tors. For electrophysiology and quantifications, HFL1 cells were transduced
with regulated and unregulated integrative vectors at an moi of 5, and with
regulated and unregulated nonintegrative vectors with and moi 10 repeated
twice.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde and preincubated for 15 min in
blocking solution (5% normal serum and 0.25% Triton-X in 0.1 M potas-
sium-buffered PBS). The primary antibodies (Table S1) were diluted in the
blocking solution and applied overnight at 4C. Fluorophore-conjugated
secondary antibodies (Molecular Probes or Jackson ImmunoResearch Labo-
ratories) were diluted in blocking solution and applied for 2 hr followed by three
rinses in potassium PBS.
qRT-PCR Analysis for mir-124 and Subtype-Specific Gene
Expression
Total RNA, including miRNA, was extracted from unconverted human
fibroblast, sorted hNCAM-positive and -negative cells using the miRNeasy
kit (QIAGEN) followed by Universal cDNA synthesis kit (Fermentas, for subtype
analysis; Exiqon for miRNA expression). Specifications of these procedures
are detailed in Supplemental Experimental Procedures.
Quantifications and Efficiency Calculation
All quantifications were calculated based on data fromminimum of three inde-
pendent experiments. To quantify the conversion efficiency (Vierbuchen et al.,
2010), total number of hNCAM-positive cells at the time point of analysis (12
and 24 days as stated) was divided by the number of fibroblasts initially plated
for conversion. To determine neuronal purity (Ladewig et al., 2012), the number
of hNCAM-positive cells was divided by the total number of cells (as deter-(E and F) Neuronal marker MAP2 is expressed in hiN converted with nonintegrat
(G–L) Whole-cell patch-clamp measurement of miR-124.T-regulated nonintegra
responses after current induction to evoke action potential (AP) in the two groups
one showed AP) (I, n = 7 where all cells showed AP after current injection). (J) No
whereas all of the cells in regulated group did (K). (L) One cell in the ABM-miR12
Scale bar, 100 mm. See also Figure S3.
Cell Remined by DAPI) present at the time point of quantification (12 and 24 days
as stated).
Electrophysiology
For electrophysiology information, seeSupplemental Experimental Procedures.
Statistical Analysis
All data are expressed as mean ± SD of the mean. An alpha level of p < 0.05
was set for significance. A two-tailed Student’s t test was used to compare
the downregulation GFP in converted HFL1-GFP and HFL1-GFP-mir-124.T
cells, difference in conversion efficiency, purity, and electrophysiological prop-
erties between mir-124.T-regulated and -nonregulated ABM-converted cells.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.11.017.
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